|
MechanismH1 receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date18 Dec 1996 |
100 Clinical Results associated with Beijing Shangxiutang Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Shangxiutang Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Shangxiutang Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Shangxiutang Pharmaceutical Technology Co., Ltd.